CYIO.US CYIOS Corporation
- Market cap
- USD 218K
- P/E
- -
- P/B
- 1.52x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is CYIO.US undervalued?
Graham numberThe Graham number of CYIOS Corporation cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CYIOS Corporation fundamental analysis
No fundamental analysis for CYIOS Corporation yet.
CYIOS Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CYIOS Corporation
CYIOS Corporation operates as a holding company that engages in resale of medical devices. The company, through its subsidiary, delivers products to healthcare providers. CYIOS Corporation was founded in 1997 and is based in Deerfield Beach, Florida.
Full company profileCYIOS Corporation financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CYIOS Corporation annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | - | - | - | 39.6K | 744K | 102K | 37.0K | 8.02M | 11.9M | - |
| Gross Profit | - | - | - | - | 14.4K | -32.7K | 57.5K | 35.1K | 534K | 665K | - |
| Operating Income | -228K | -1.55K | -1.70K | -80.4K | -723K | -1.20M | -1.08M | -456K | -193K | 38.5K | -206K |
| EBITDA | -227K | -1.26K | -1.40K | 97.1K | -517K | -1.12M | -1.32M | 128K | -908K | 38.5K | -206K |
| Net Income | -233K | -8.44K | -8.92K | -85.3K | -737K | -2.89M | -2.38M | -365K | -1.31M | 497K | -1.76M |
| EPS | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 10.4K | 10.7K | 11.0K | 2.08K | 60.1K | 1.57M | 1.05M | 1.02M | 959K | 969K | 43.00 |
| Total Liabilities | 232K | 241K | 250K | 318K | 590K | 1.68M | 2.51M | 2.53M | 2.99M | 2.63M | 2.50M |
| Shareholders' Equity | -222K | -231K | -239K | -316K | -529K | -107K | -1.46M | -1.51M | -2.03M | -1.66M | -2.50M |
| Cash & Short-term Investments | - | - | - | - | 38.5K | 338K | 112.00 | 6.66K | 29.2K | 223.00 | 43.00 |
| Total Debt | 231K | 237K | 247K | 318K | 409K | 1.60M | 2.09M | 2.02M | 2.36M | 2.15M | 2.03M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -226K | 288.00 | -3.05K | -40.4K | -576K | -917K | -850K | -58.8K | -297K | -401K | -6.76K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 5.00 | 2.00 | 4.00 | 0.00 |
| Free Cash Flow | -226K | 288.00 | -3.05K | -40.4K | -576K | -917K | -850K | -58.8K | -297K | -401K | -6.76K |
| Ratios | |||||||||||
| ROA | -2,243.0% | -79.1% | -81.3% | -4,109.8% | -1,225.5% | -184.2% | -227.9% | -36.0% | -136.3% | 51.3% | -4,085,353.5% |
| Net Profit Margin | - | - | - | - | -1,862.8% | -388.2% | -2,345.3% | -987.2% | -16.3% | 4.2% | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
CYIOS Corporation dividends
CYIOS Corporation has not paid dividends in the last 9 fiscal years.
Last stock split: 1:30 on May 17, 2005.
Who owns CYIOS Corporation
Ownership data of CYIOS Corporation is not available yet.
CYIOS Corporation company profile
- Company name
- CYIOS Corporation
- Ticker
- CYIO.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Industrial Conglomerates
- Employees
- 15
- Fiscal year end
- December
- Address
- 258 South Military Trail, Deerfield Beach, FL, United States, 33442
- Phone
- 617 504 3635
- Website
- cyioscorporation.com
About CYIOS Corporation
CYIOS Corporation operates as a holding company that engages in resale of medical devices. The company, through its subsidiary, delivers products to healthcare providers. CYIOS Corporation was founded in 1997 and is based in Deerfield Beach, Florida.
CYIOS Corporation management
2- Mr. John Fredrick O'SheaCEO & Chairman of the Board · born 1968
- Mr. Jonathan D. Leinwand Esq.Legal council · born 1970